Involvement of ERK and CREB signaling pathways in the protective effect of PACAP in monosodium glutamate-induced retinal lesion

Annals of the New York Academy of Sciences

Volumn 1070, Issue , 2006, Pages 507-511

  Rácz, Boglarka ^a   Tamás, Andrea ^a   Kiss, Peter ^a   Tóth, Gabor ^b   Gasz, Balazs ^a   Borsiczky, Balazs ^a   Ferencz, Andrea ^a   Gallyas Jr , Ferenc ^c   Roth, Erzsebet ^a   Reglodi, Dora ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

^c UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Intravitreal; Neonatal rat; Neuroprotection

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GLUTAMATE SODIUM; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; ENZYME ACTIVATION; EYE; NEUROPROTECTION; NEWBORN; NONHUMAN; PROTEIN PHOSPHORYLATION; RAT; RETINA DEGENERATION; WESTERN BLOTTING;

EID: 33746467019     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1317.070     Document Type: Conference Paper

References (13)

1. SEKI, T. et al. 1997. Distribution and ultrastructural localization of a receptor for pituitary adenylate cyclase activating polypeptide and its mRNA in the rat retina [abstract]. Neurosci. Lett. 238: 127-130.
2. IZUMI, S. et al. 2000. Ultrastructural localization of PACAP immunoreactivity in the rat retina. Ann. N. Y. Acad. Sci. 921: 317-320.
3. HANNIBAL, J. 2002. Neurotransmitters of the retino-hypothalamic tract. Cell Tissue Res. 309: 73-88.
4. SOMOGYVARI-VIGH, A. & D. REGLODI. 2004. Pituitary adenylate cyclase activating polypeptide: a potential neuroprotective peptide. Review. Curr. Pharm. Des. 10: 2861-2889.
5. RABL, K. et al. 2002. PACAP inhibits anoxia-induced changes in physiological responses in horizontal cells in the turtle retina. Regul. Pept. 109: 71-74.
6. SEKI, T. et al. 2003. Pituitary adenylate cyclase activating polypeptide (PACAP) protects against ganglion cell death after cutting of optic nerve in the rat retina [abstract]. Regul. Pept. 115: 55.
7. SHOGE, K. et al. 1999. Attenuation by PACAP of glutamate-induced neurotoxicity in cultured retinal neurons. Brain Res. 839: 66-73.
8. TAMAS, A. et al. 2004. Effects of pituitary adenylate cyclase activating polypeptide in retinal degeneration induced by monosodium-glutamate. Neurosci. Lett. 372: 110-113.
9. VAUDRY, D. et al. 2002. PACAP protects cerebellar granule neurons against oxidative stress-induced apoptosis. Eur. J. Neurosci. 15: 1451-1460.
10. SHIODA, S. et al. 1998. PACAP protects hippocampal neurons against apoptosis: involvement of JNK/SAPK signaling pathway. Ann. N. Y. Acad. Sci. 865: 111-117.
11. BABAI, N. et al. 2005. Degree of damage compensation by various PACAP treatments in monosodium glutamate-induced retina degeneration. Neurotox. Res. 8: 227-233.
12. VAUDRY, D. et al. 1998. Pituitary adenylate cyclase activating polypeptide stimulates both c-fos gene expression and cell survival in rat cerebellar granule neurons through activation of the protein kinase A pathway. Neuroscience 84: 801-812.
13. FIGIEL, M. & J. ENGELE. 2000. Pituitary adenylate cyclase activating polypeptide (PACAP), a neuron-derived peptide regulating glial glutamate transport and metabolism. J. Neurosci. 20: 3596-3605.